1-3 of 3
Geqiang Li, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic and Pharmacologic Targeting of STAT5/Gab2/PI3K/mTOR Signaling in a Mouse Myeloproliferative Disease Model.

Geqiang Li, Ph.D., Zhengqi Wang, Ph.D., Kristy L. Miskimen, Ph.D., Xiu Yan Xie, M.D., William Tse, M.D., Fabrice Gouilleux, Ph.D., Richard Moriggl, Ph.D., Kevin D. Bunting, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 3902.
https://doi.org/10.1182/blood.V114.22.3902.3902
Published: 2009
Journal Articles

STAT5 Requires the N-Domain for Suppression of miR15/16, Induction of Bcl-2, and Survival Signaling in Myeloproliferative Disease.

Geqiang Li, Ph.D., Kristy L. Miskimen, Ph.D., Zhengqi Wang, Ph.D., Xiu Yan Xie, M.D., Jennifer Brenzovich, B.S., John J Ryan, Ph.D., William Tse, M.D., Richard Moriggl, Ph.D., Kevin D. Bunting, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 211.
https://doi.org/10.1182/blood.V114.22.211.211
Published: 2009
Journal Articles

Conditional Deletion of STAT5 in Non-Myeloablated Recipient Mice Promotes Donor Hematopoietic Stem Cell Engraftment.

Zhengqi Wang, PhD, Geqiang Li, Ph.D., Eleonora Haviernikova, M.S., William Tse, M.D., Kevin D. Bunting, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 178.
https://doi.org/10.1182/blood.V110.11.178.178
Published: 2007